New Key Statistics Module, Z-Score and F-Score
SZSE:002437 Key Ratios
Market Cap ¥ M | 4,155.04 |
Enterprise Value ¥ M | 3,947.71 |
P/E(ttm) | 26.14 |
PE Ratio without NRI | 23.16 |
Forward PE Ratio | -- |
Price/Book | 2.29 |
Price/Sales | 1.59 |
Price/Free Cash Flow | 12.80 |
Price/Owner Earnings | 33.88 |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 2,538.00 |
EPS (TTM) ¥ | 0.07 |
Beneish M-Score | -2.93 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 16.03 |
EV-to-EBITDA | 16.03 |
PEG | -- |
Shares Outstanding M | 2,270.51 |
Net Margin (%) | 6.01 |
Operating Margin % | 10.14 |
Pre-tax Margin (%) | 8.40 |
Quick Ratio | 0.78 |
Current Ratio | 0.94 |
ROA % (ttm) | 4.39 |
ROE % (ttm) | 8.90 |
ROIC % (ttm) | 6.59 |
Dividend Yield % | -- |
Altman Z-Score | 2.79 |
SZSE:002437 Number of Guru Trades
SZSE:002437 Volume of Guru Trades
Gurus Latest Trades with SZSE:002437
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002437 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Harbin Gloria Pharmaceuticals Co Ltd Insider Transactions
No Available Data